Article info

PDF
Research paper
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
  1. Correspondence to Dr M H Soilu-Hänninen, University Hospital of Turku, Department of Neurology, Kiinamyllynkatu 4-8, Turku FIN-20520, Finland; mersoi{at}utu.fi
View Full Text

Citation

Soilu-Hänninen M, Åivo J, Lindström B, et al
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

Publication history

  • Received November 24, 2011
  • Revised January 28, 2012
  • Accepted January 30, 2012
  • First published February 22, 2012.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.